Patents for A01K 67 - Rearing or breeding animals, not otherwise provided for; New breeds of animals (34,042)
11/2004
11/11/2004US20040224910 Recombinant nematode nicotinic receptor and uses
11/11/2004US20040224885 Methods of treating hypertension and compositions for use therein
11/11/2004US20040224882 modulating cell growth, cell differentiation, or cell survival; genetic engineering using hedgehog genes and proteins; neurodegenerative diseases; tissue-targeted therapy
11/11/2004US20040224878 Fertilization of aged oocytes
11/11/2004US20040224407 Expression vector for consistent cellular expression of the tet on repressor in multiple cell types
11/11/2004US20040224314 G-protein coupled receptors
11/11/2004US20040224313 Comprises nucleotide sequences coding cytochrome p450 oxygenase variant for identifying modulator use in diagnosis, prognosis, treatment and prevention of cell proliferative disorders; antitumor agents
11/11/2004CA2528143A1 Method of diagnosing a genetic susceptibility for bone damage
11/11/2004CA2523751A1 Array having substances fixed on support arranged with chromosomal order or sequence position information added thereto, process for producing the same, analytical system using the array and use of these
11/11/2004CA2523537A1 Pathophysiology associated with a single gene (mass1) mutation underlying the robust audiogenic seizure phenotype in frings mice
11/11/2004CA2522154A1 Recombinant plant dicer
11/10/2004EP1475436A1 Swine rag-1 gene and utilization thereof
11/10/2004EP1474682A2 Production of human antibodies in immunodeficient, non-human, mammalian hosts
11/10/2004EP1474520A2 Prkag3 gene promoter and uses thereof
11/10/2004EP1474517A2 Mutated gene coding for a lat protein and the biological applications thereof
11/10/2004EP1474508A2 Phytase variants
11/10/2004EP1474448A1 Rrp sequences and knockout mice and uses thereof
11/10/2004EP1473990A2 Cardiac-specific 11 beta hydroxysteroid dehydrogenase type 2 transgenic mice
11/10/2004EP1202629B1 Insect control system
11/10/2004EP1003366A4 Methods for producing sialyloligosaccharides in a dairy source
11/09/2004US6815575 For identifying genes that prevent cell/tissue (neural, muscle, mesoderm, kidney) degradation/apoptosis using transgenic drosophila
11/09/2004US6815574 Methods of simulating human prostate cancer progression
11/09/2004US6814279 Cricket box
11/04/2004WO2004095032A1 Screen for pre-eclampsia
11/04/2004WO2004095024A1 Probe for detecting and quantifying lipid second messenger and method of detecting and quantifying lipid second messenger using the same
11/04/2004WO2004094617A2 Sensin polypeptides, encoding nucleic acids, mutations, and methods of their identification and use
11/04/2004WO2004094603A2 Transgenic mouse with simplified dh locus
11/04/2004WO2004094597A2 Anthozoan fluorescent protein genes
11/04/2004WO2004094594A2 Non-human animal model for graft-versus-host disease
11/04/2004WO2004093907A2 Therapeutic agents for treating dermatitis, alopecia and itching and transgenic animals for evaluating such therapeutic agents
11/04/2004WO2004093830A2 Model for neurodegenerative disorders
11/04/2004WO2004093788A2 Desmoglein 4 is a novel gene involved in hair growth
11/04/2004WO2004093535A1 Tumour model
11/04/2004WO2004084808A3 Animal with surgically modified gastrointestinal tract and method for study of weight reduction
11/04/2004WO2004075912B1 Use of pgrp, lrrp and ctl proteins to trigger an anti-plasmodium immune response in anopheles species
11/04/2004WO2004061077A3 Increasing gamete production with a gene switch
11/04/2004WO2004050847A3 Modified antibodies stably produced in milk and methods of producing same
11/04/2004WO2004024227A3 Systems of sperm cell preservation and processing
11/04/2004WO2004019676A3 Animal model for perimenopause and menopause and methods of inducing ovarian failure
11/04/2004WO2003092612A3 VECTORS HAVING BOTH ISOFORMS OF β-HEXOSAMINIDASE
11/04/2004WO2003069984A9 Transgenic production in saliva
11/04/2004WO2003062270A8 Fluorescent protein from aequorea coerulscens and uses therof
11/04/2004US20040221326 Transgenic animal model of bone mass modulation
11/04/2004US20040220107 Glycosylation-resistant cyanovirins and related conjugates, compositions, nucleic acids, vectors, host cells, methods of production and methods of using nonglycosylated cyanovirins
11/04/2004US20040219562 Novel form of the PHGPx protein as a diagnostic marker for male infertility
11/04/2004US20040219507 A separation device for recovering and preparing motile sperm for intracytoplasmic sperm injection (ICSI); artificial insemination
11/04/2004CA2809164A1 Postnatal stem cells and uses thereof
11/04/2004CA2522285A1 Screen for pre-eclampsia
11/04/2004CA2522184A1 Desmoglein 4 is a novel gene involved in hair growth
11/04/2004CA2520424A1 Model for neurodegenerative disorders
11/03/2004EP1472379A1 Polymorphisms in the human gene for tpmt and their use in diagnostic and therapeutic applications
11/03/2004EP1472373A2 Methods for making polynucleotides and purifying double-stranded polynucleotides
11/03/2004EP1471971A2 Method and apparatus for guiding movement of a freely roaming animal through brain stimulation
11/03/2004EP1471938A2 Human monoclonal antibodies against cd30
11/03/2004EP1471926A2 Compositions and methods for the therapeutic use of an atonal-associated sequence
11/03/2004EP1471922A2 METHODS AND MATERIALS FOR MODULATING TASK−3
11/03/2004EP0928332B1 Process for developing mammals with definite genetic features
11/03/2004CN1543508A Test systems and the use thereof for identifying and characterizing compounds
11/03/2004CN1543317A Methods and apparatus for customizing pet food
11/03/2004CN1543316A Method and apparatus for customizing a multiple component pet food
11/02/2004US6812014 Isolated human kinase proteins, nucleic acid molecules encoding human kinase proteins and uses thereof
10/2004
10/28/2004WO2004092371A1 Mouse with deficiency of glutamate trasnporter glast function
10/28/2004WO2004092358A1 Implement and method for freezing and storing egg
10/28/2004WO2004092351A2 Production of a transgenic avian by cytoplasmic injection
10/28/2004WO2004092220A1 Methods for ex vivo hybridoma-free production of polyclonal and monoclonal antibodies and generation of immortalized cell populations
10/28/2004WO2004091288A2 Correcting mitotic spindle defects in somatic cell nuclear transfer
10/28/2004WO2004056857A3 Use of the multifunctional transcription factor yin-yang-1 and variants thereof for treating illnesses, especially type 1 diabetes
10/28/2004WO2004003157A3 Gene regulation in transgenic animals using a transposon-based vector
10/28/2004WO2003020954A3 205p1b5 in treatment and detection of cancer
10/28/2004WO2001081540A3 Growth factor which acts through erb b-4 rtk
10/28/2004US20040216180 Nucleic acids encoding linked chromo/fluorescent domains and methods for using the same
10/28/2004US20040216179 Recombinant plasmid expressing two fluorescence genes
10/28/2004US20040216178 Knockout expression vector which targets preferential ocogenic gene for use as tool in treatment of cell proliferative diseases
10/28/2004US20040216177 Congenic rats containing a mutant GPR10 gene
10/28/2004US20040216176 Compositions and methods for characterizing and regulating Wnt pathways
10/28/2004US20040216175 Screen for detecting and identifying toxic agents which utilizes animal cleavage stage embryos and enhanced transcriptional patterns
10/28/2004US20040214995 Melanoma antigens and their use in diagnostic and therapeutic methods
10/28/2004US20040214275 Von willebrand factor (vmf)-cleaving enzyme
10/28/2004US20040214270 Isocitrate dehydrogenase, gene thereof, and use of the same in the treatment of obesity, hyperlipidemia, and fattly liver in lipid biosynthesis
10/28/2004US20040214264 Comprises nucleotide sequences coding dimethylarginine dimethylaminohydrolase-1 protein (DDAH1) for use in identifying modulators for treatment of diabetes and cardiovascular disorders
10/28/2004US20040214247 Comprises immunoglobulin which binds to tumor specific epitope and inhibits binding of matrix protein/collagen/gelatin complexes; immunotherapy and antitumor agents
10/28/2004US20040214192 Diagnosing allergies via measuring expression of nuclear orphan receptor (NOR-1 receptor) gene; identifying modulators for treating atopic dermatitis
10/28/2004CA2522597A1 Mouse deficient in glutamate transporter glast function
10/28/2004CA2522207A1 Methods for ex vivo hybridoma-free production of polyclonal and monoclonal antibodies and generation of immortalized cell populations
10/27/2004EP1470222A2 Transgenic animal comprising intracellular immunoglobins for xenotransplantation
10/27/2004EP1470155A2 Pluripotency determining factors and uses thereof
10/27/2004EP1470115A1 Treatment of male sexual dysfunction
10/27/2004EP1469877A2 B-cell lymphoma specific antigen for use in diagnosis and treatment of b-cell malignancies
10/27/2004EP1469717A2 Triple transgenic mouse model of alzheimer's disease
10/27/2004EP1276851B1 Tolerance-inducing thymus-bone marrow composite tissue construct and organ
10/27/2004EP0782862B1 Genetic material containing composition
10/27/2004CN2650503Y Factorial culturing pool for stichopus japonicus
10/27/2004CN1541367A Pet food kiosk
10/27/2004CN1539849A Polypeptides encoded by haman lipase-like gene and compsns, and metods of utilizing same
10/27/2004CN1539275A Method and equipment for rearing domestic silkworm and fullgrown silkworm
10/27/2004CN1539274A Method for growing duck in paddyfield
10/27/2004CN1539273A Method for ecotypic breeding frog
10/27/2004CN1173039C Variant loxP sequences and application of the same
10/27/2004CN1172583C Method of storaging and treating fresh silkworm cocoon
10/26/2004US6808704 Removing nuclear dna from recipient oocyte to form nuclear transfer agent; activating and culturing to generate non-human embryo; injecting into donor mammal; examining site for teratoma and signs of rejection